|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00557635 |
|
Date of registration:
|
12/11/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow
|
|
Scientific title:
|
Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow |
|
Date of first enrolment:
|
January 2008 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Suspended |
|
URL:
|
http://clinicaltrials.gov/show/NCT00557635 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Contacts
|
|
Name:
|
Marc Berger, Dr |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- tibia or femur pseudo-arthrosis,
- patient who needs bone graft
Exclusion Criteria:
- - contra indications for chirurgical intervention or bone graft
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Tibia or Femur Pseudo-arthrosis
|
|
Intervention(s)
|
|
Procedure: Chirurgical procedure
|
|
Primary Outcome(s)
|
|
Evaluate osseous setting at 3-months follow-up and compare our results with past studies
[Time Frame: at 3-months follow-up]
|
|
Secondary Outcome(s)
|
|
Feasibility and tolerance of this therapeutic strategy
[Time Frame: at 3-months follow-up]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|